Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,833 | -32,177 | -24,533 | -17,240 | -584 |
| Depreciation Amortization | 239 | 1,463 | 1,053 | 698 | 347 |
| Accounts receivable | -11,226 | -1,211 | -3,297 | -143 | 334 |
| Other Working Capital | -6,035 | -350 | 1,443 | 1,795 | 419 |
| Other Operating Activity | 5,123 | 17,066 | 12,013 | 4,342 | -6,828 |
| Operating Cash Flow | $-10,066 | $-15,209 | $-13,321 | $-10,548 | $-6,312 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -7 | -5 | N/A | -1 |
| PPE Investments | -227 | -832 | -628 | -340 | -207 |
| Net Acquisitions | N/A | N/A | N/A | -3 | N/A |
| Purchase Sale Intangibles | -109 | -1,122 | -821 | -622 | -297 |
| Other Investing Activity | -109 | -1,122 | -821 | -622 | -297 |
| Investing Cash Flow | $-336 | $-1,961 | $-1,454 | $-965 | $-505 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -20 | -77 | -58 | -39 | -20 |
| Common Stock Issued | 116 | 2,561 | 2,525 | 19 | N/A |
| Financing Cash Flow | $96 | $2,484 | $2,467 | $-20 | $-20 |
| Beginning Cash Position | 33,589 | 48,275 | 48,275 | 48,275 | 48,275 |
| End Cash Position | 23,283 | 33,589 | 35,967 | 36,742 | 41,438 |
| Net Cash Flow | $-10,306 | $-14,686 | $-12,308 | $-11,533 | $-6,837 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,066 | -15,209 | -13,321 | -10,548 | -6,312 |
| Capital Expenditure | -227 | -832 | -628 | -340 | -207 |
| Free Cash Flow | -10,293 | -16,041 | -13,949 | -10,888 | -6,519 |